Xeris Biopharma Holdings, Inc. (XERS)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 1.8600 |
| 開市 | 1.9000 |
| 買盤 | 1.8700 x 600 |
| 賣出價 | 1.9000 x 600 |
| 今日波幅 | 1.8400 - 1.9300 |
| 52 週波幅 | 1.4600 - 3.2600 |
| 成交量 | |
| 平均成交量 | 1,873,464 |
| 市值 | 280.2M |
| Beta 值 (5 年，每月) | 1.11 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.4500 |
| 業績公佈日 | 2024年3月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 4.75 |
ZacksStrength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Insider MonkeyXeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2023 Earnings Call Transcript March 6, 2024 Xeris Biopharma Holdings, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello everyone and welcome to the Xeris fourth quarter and full year 2023 financial results […]
ZacksXeris Biopharma (XERS) Reports Q4 Loss, Lags Revenue Estimates
Xeris Biopharma (XERS) delivered earnings and revenue surprises of -11.11% and 2.44%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
